Your weekly roundup of the latest news from Drug Topics®.
Study finds growth in three years after CDC guideline for primary care clinicians.
The risk could allow unauthorized users to change insulin levels.
A national study in Germany identified the baseline characteristics of patients with moderate-to-severe atopic dermatitis to understand how they are usually treated with Dupixent in the real world.
Hospitalization, disability, having private high-deductible, Medicare Advantage, or no coverage were risk factors associated with medical debt.
Research indicates that using an open-source automated insulin delivery systems can lead to greater glycemic control.
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.